EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A highly selective KIT inhibitor MOD000001 suppresses IgE-mediated mast cell activation

Yuki Nakamura, Takeo Urakami, Kayoko Ishimaru, Nguyen Quoc Vuong Tran, Takafumi Shimizu, William Sinko, Taisuke Takahashi, Sivapriya Marappan, Kishore Narayanan, Ramulu Poddutoori, Yoh Terada, Atsuhito Nakao

Journal of Allergy and Clinical Immunology: Global · 2024-08 · 3 (3) · 100249

DOI: 10.1016/j.jacig.2024.100249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology: Global, 2024-08. Verfasst von Yuki Nakamura und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Government of Japan Ministry of Education Culture Sports Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The KIT receptor tyrosine kinase and its ligand, stem cell factor (SCF), control proliferation and survival of mast cells. Thus, targeting KIT signaling may show promise for the treatment of allergic diseases involving mast cells. Recently, we discovered a new compound, MOD000001, as a potential small-molecule KIT kinase inhibitor by using an in silico approach.

Objective

We sought to determine whether MOD000001 is highly selective to KIT, inhibits KIT signaling in mast cells, and affects IgE-mediated mast cell activation.

Methods

The interaction of MOD000001 with 468 human kinases and its inhibitory activity against KIT were profiled and evaluated by using KINOMEscan (Discover X/Eurofins Corporation, Fremont, Calif) and cell-free kinase assays, respectively. The effects of MOD000001 on SCF-dependent signaling were examined by using primary mouse and human mast cells. The effects of MOD000001 on SCF-induced degranulation and passive cutaneous anaphylaxis reaction were examined in mice.

Results

MOD000001 interacted with KIT and inhibited KIT kinase activity with high selectivity. MOD000001 suppressed SCF-induced KIT signaling in mouse and human mast cells and in mice. Passive cutaneous anaphylaxis reaction was suppressed in mice treated with MOD000001 both for a short-term (1 week) and for a long-term (7 weeks). Mice treated with MOD000001 for a long-term, but not for a short-term, showed skin mast cell reduction.

Conclusions

MOD000001 is a highly selective KIT inhibitor that can suppress IgE-mediated mast cell activation in vivo. MOD000001 may do so by reducing tissue mast cell numbers or by other unknown mechanisms. The findings suggest potential benefits of MOD000001 for allergic diseases involving IgE-mediated mast cell activation.

Schlagwörter

Stichwörter der Autor:innen

IgEKIT inhibitorallergymast cells

Autor:innen und Institutionen

  • Department of Immunology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
  • Alivexis, Inc, Tokyo, Japan.
  • Aurigene Oncology, Ltd, Bangalore, India.
  • Yamanashi GLIA Center, University of Yamanashi, Yamanashi, Japan.
  • Atopy Research Center, Juntendo University School of Medicine, Tokyo, Japan.

Förderung

  • Government of Japan Ministry of Education Culture Sports Science and Technology

Zitieren

APA

Nakamura, Y., Urakami, T., Ishimaru, K., Vuong Tran, N. Q., Shimizu, T., Sinko, W., Takahashi, T., Marappan, S., Narayanan, K., Poddutoori, R., Terada, Y., & Nakao, A. (2024). A highly selective KIT inhibitor MOD000001 suppresses IgE-mediated mast cell activation. Journal of Allergy and Clinical Immunology: Global, 3(3), 100249. https://doi.org/10.1016/j.jacig.2024.100249

Vancouver

Nakamura Y, Urakami T, Ishimaru K, Vuong Tran NQ, Shimizu T, Sinko W, et al. A highly selective KIT inhibitor MOD000001 suppresses IgE-mediated mast cell activation. Journal of Allergy and Clinical Immunology: Global. 2024;3(3):100249. doi:10.1016/j.jacig.2024.100249

BibTeX
@article{Nakamura2024,
  author = {Nakamura, Yuki and Urakami, Takeo and Ishimaru, Kayoko and Vuong Tran, Nguyen Quoc and Shimizu, Takafumi and Sinko, William and Takahashi, Taisuke and Marappan, Sivapriya and Narayanan, Kishore and Poddutoori, Ramulu and Terada, Yoh and Nakao, Atsuhito},
  title = {A highly selective KIT inhibitor MOD000001 suppresses IgE-mediated mast cell activation},
  journal = {Journal of Allergy and Clinical Immunology: Global},
  year = {2024},
  volume = {3},
  number = {3},
  pages = {100249},
  doi = {10.1016/j.jacig.2024.100249}
}
Kostenlos starten →